Article | April 24, 2019

Patient-Centricity: A Drug Development Imperative

Source: AbbVie

By Michael Dennis, Director of Technical Operations, Science and Technology, AbbVie and Bill Huang, Sr. Principal Research Scientist, Formulation Sciences, AbbVie.

patient with pill

Success in the pharmaceutical industry is about more than the efficacy of compounds. It’s about facilitating positive patient outcomes. We know positive outcomes are in no small part dependent on the patient’s acceptance and administration of—and ultimately their experience with—the therapies we create. The connection between drug manufacturing and patient outcomes is not in question; but how much is patient-centricity influencing the process of therapy development today, and how much room does the industry have for further patient-centric improvement? 

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: